Cargando…
Is preclinical research in cancer biology reproducible enough?
The Reproducibility Project: Cancer Biology (RPCB) was established to provide evidence about reproducibility in basic and preclinical cancer research, and to identify the factors that influence reproducibility more generally. In this commentary we address some of the scientific, ethical and policy i...
Autores principales: | Kane, Patrick Bodilly, Kimmelman, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651283/ https://www.ncbi.nlm.nih.gov/pubmed/34874006 http://dx.doi.org/10.7554/eLife.67527 |
Ejemplares similares
-
Can cancer researchers accurately judge whether preclinical reports will reproduce?
por: Benjamin, Daniel, et al.
Publicado: (2017) -
Investigating the replicability of preclinical cancer biology
por: Errington, Timothy M, et al.
Publicado: (2021) -
Challenges for assessing replicability in preclinical cancer biology
por: Errington, Timothy M, et al.
Publicado: (2021) -
Experiments from unfinished Registered Reports in the Reproducibility Project: Cancer Biology
por: Errington, Timothy M, et al.
Publicado: (2021) -
Comparison of Patient and Expert Perceptions of the Attainment of Research Milestones in Parkinson's Disease
por: Kane, Patrick Bodilly, et al.
Publicado: (2020)